Bortezomib as a new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm

Blastic plasmacytoid dendritic cell neoplasm is an aggressive hematologic malignancy with a poor prognosis. No consensus regarding optimal treatment modalities is currently available. Targeting the nuclear factor-kappa B pathway is considered a promising approach since blastic plasmacytoid dendritic...

Descripción completa

Detalles Bibliográficos
Autores principales: Philippe, Laure, Ceroi, Adam, Bôle-Richard, Elodie, Jenvrin, Alizée, Biichle, Sabeha, Perrin, Sophie, Limat, Samuel, Bonnefoy, Francis, Deconinck, Eric, Saas, Philippe, Garnache-Ottou, Francine, Angelot-Delettre, Fanny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664390/
https://www.ncbi.nlm.nih.gov/pubmed/28798071
http://dx.doi.org/10.3324/haematol.2017.169326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5664390/
https://www.ncbi.nlm.nih.gov/pubmed/28798071
http://dx.doi.org/10.3324/haematol.2017.169326

Ejemplares similares